Community-reported Delursan side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Delursan Side Effect
Have You dealt with a Delursan side effect? Share your experience
Review Delursan Safety Reports submitted to FDA
Total Delursan reports: 5.Delursan FDA safety alerts: No.
Reported hospitalizations: 5.
Take Delursan Side Effects Survey, Discuss Delursan with others
FDA Reported Delursan Side Effects: renal failure acute, rash, pneumonia, pancytopenia, oedema peripheral, lung infection pseudomonal, transaminases increased, jaundice, hepatic pain.
More About Delursan.
If you have questions about Delursan, you can ask a Health Expert or Ask Patient Community about Delursan.
Featured polls
- What did you do to overcome side effect?
- Did you and your doctor discuss the risks and side effects of the drug, or not?
- When you are buying over the counter medication for the first time how often, if ever, do you look for warnings about possible side effects?
- When you have a prescription filled, how often does the pharmacist tell you about side effects you may experience?
- Have you, personally, ever attempted to lose weight in your lifetime, or not?
- How easy or hard do you think it is for most people who are very overweight to lose weight?
Delursan Side Effects Report #5483897-6
Consumer or non-health professional from FRANCE reported DELURSAN problem on Sept 26, 2007. Female patient, 88 years of age, was diagnosed with cholelithiasis, atrial fibrillation, depression, anaemia and was treated with DELURSAN. After drug was administered, patient experienced the following problems/side effects: abdominal tenderness, anaemia, constipation, faecaloma, flatulence, pallor, peritoneal effusion, renal failure acute, small intestinal haemorrhage. DELURSAN dosage: 250 MG; ORAL. During the same period patient was treated with PREVISCAN, CORDARONE, DEROXAT, FOLIC ACID, OMEPRAZOLE, PRIMAXIN. Patient was hospitalized. Patient recovered.
Delursan Side Effects Report #5383614-4
DELURSAN problem was reported by a Consumer or non-health professional from FRANCE on June 21, 2007. Male patient, 47 years of age, was treated with DELURSAN. After drug was administered, patient experienced the following problems/side effects: lung infection pseudomonal, oedema peripheral, pancytopenia, pneumonia, rash, renal failure acute. DELURSAN dosage: 500 MG ORAL. During the same period patient was treated with ALLOPURINOL, CERTICAN, CYCLOSPORINE, ASPEGIC, IMURAN. Patient was hospitalized. Patient recovered.
Delursan Side Effects Report #5383614-4
Consumer or non-health professional from FRANCE reported DELURSAN problem on June 21, 2007. Male patient, 47 years of age, was treated with DELURSAN. After drug was administered, patient experienced the following problems/side effects: lung infection pseudomonal, oedema peripheral, pancytopenia, pneumonia, rash, renal failure acute. DELURSAN dosage: 500 MG ORAL. During the same period patient was treated with ALLOPURINOL, CERTICAN, CYCLOSPORINE, ASPEGIC, IMURAN. Patient was hospitalized. Patient recovered.
Delursan Side Effects Report #5731282-1
DELURSAN problem was reported by a Consumer or non-health professional from FRANCE on Apr 22, 2008. Female patient, 85 years of age, was treated with DELURSAN. After drug was administered, patient experienced the following problems/side effects: haematuria, thrombocytopenia. DELURSAN dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, STABLON, ACTONEL, CALCIDOSE, POTASSIUM CHLORIDE, FUROSEMIDE, SOLUPRED, AMIODARONE. Patient was hospitalized. Patient recovered.
Delursan Side Effects Report #5692825-X
Consumer or non-health professional from FRANCE reported DELURSAN problem on Mar 26, 2008. Female patient, 48 years of age, was treated with DELURSAN. After drug was administered, patient experienced the following problems/side effects: asthenia, hepatic enzyme increased, pruritus. DELURSAN dosage: unknown. During the same period patient was treated with METEOSPASYMOL, SPASFON. Patient was hospitalized. Patient recovered.